Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Abbott Laboratories (ABT) vs ProShares Ultra Bitcoin ETF (BITU) Price & Performance

Abbott LaboratoriesTrade
ProShares Ultra Bitcoin ETFTrade

Price performance (Past 24H)

Key statistics

Abbott Laboratories vs ProShares Ultra Bitcoin ETF — how do they compare? Abbott Laboratories trades at $109.58 (market cap $187.95B), while ProShares Ultra Bitcoin ETF trades at $9.25. The key difference: Abbott Laboratories pays a 2.32% dividend while ProShares Ultra Bitcoin ETF pays none, and Abbott Laboratories is trading nearer its 52-week high, ProShares Ultra Bitcoin ETF nearer its low. Which is the better fit depends on your goals.

ABTBITU
Market Cap
$187.95B
Sector
HealthLeveraged / Inverse
52-Week High
$136.62$64.41
52-Week Low
$82.57$8.12
Enterprise Value
$214.96B
Dividend Yield
2.32%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Abbott Laboratories

Abbott Laboratories (ABT) trades at $108.63, up 0.77% today, near its 52-week high. The stock shows a bullish technical trend with strong moving averages, though RSI indicates overbought conditions. Fundamentally, revenue grew to $44.33B in 2025 with a net income margin of 11.65%, while recent Q1 and Q2 2026 earnings beat expectations. The company maintains solid cash flow from operations of $9.57B and recently secured CE Mark for innovative dual glucose-ketone sensors, reinforcing its healthcare leadership.

Outlook remains positive with a consensus price target of $120.70, implying 11% upside, supported by 75.6% analyst buy ratings. Key risks include competitive pressures in diagnostics and macroeconomic sensitivity. The dividend yield and innovation pipeline offer stability, but investors should monitor execution on growth initiatives amid evolving market conditions.

ProShares Ultra Bitcoin ETF

BITU's stock trades at $9.205, down 1.34% in the last 24 hours, with a bearish technical signal from moving averages and a neutral stance from oscillators. The company has declared several dividends in 2026, with the latest being $0.02 per share. Key support and resistance levels are tightly clustered around $9 to $10, indicating limited recent price movement.

The outlook for BITU is cautious due to bearish technical indicators and negative sentiment from financial media. Investment opportunities may exist for dividend-focused investors, but risks include potential underperformance highlighted by analysts and market volatility. The stock's proximity to support levels suggests vulnerability to further declines.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Abbott Laboratories

Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.

Read more on ABT

About ProShares Ultra Bitcoin ETF

BITU is a leveraged ETF that seeks to provide two times (2x) the daily performance of Bitcoin. It is designed for sophisticated investors looking for magnified exposure to Bitcoin’s daily price movements.

Read more on BITU